Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies

View ORCID ProfileShubham Misra, Kavitha Kolappa, Manya Prasad, Divya Radhakrishnan, Kiran T Thakur, Tom Solomon, Benedict Daniel Michael, Andrea Sylvia Winkler, Ettore Beghi, Alla Guekht, View ORCID ProfileCarlos A. Pardo, Greta Karen Wood, Sherry Hsiang-Yi Chou, Ericka L. Fink, Erich Schmutzhard, Amir Kheradmand, Fan Kee Hoo, Amit Kumar, Animesh Das, Achal K Srivastava, Ayush Agarwal, Tarun Dua, Kameshwar Prasad
doi: https://doi.org/10.1101/2021.04.20.21255780
Shubham Misra
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shubham Misra
Kavitha Kolappa
2World Health Organization, Brain Health Unit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manya Prasad
3Department of Clinical research and Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Divya Radhakrishnan
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiran T Thakur
4Columbia University Irving Medical Center-New York Presbyterian Hospital, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Solomon
5Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 7BE UK
6Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, L9 7LJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedict Daniel Michael
5Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 7BE UK
6Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, L9 7LJ, UK
7NIHR Health Protection Research Unit for Emerging and Zoonotic Infection, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Sylvia Winkler
8Center for Global Health, Department of Neurology, Technical University of Munich, Germany
9Centre for Global Health, Institute of Health and Society, University of Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ettore Beghi
10Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alla Guekht
11Moscow Research and Clinical Center for Neuropsychiatry and Pirogov Russian National Research Medical University; Moscow Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos A. Pardo
12Departments of Neurology and Pathology, Johns Hopkins University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos A. Pardo
Greta Karen Wood
5Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L69 7BE UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherry Hsiang-Yi Chou
13University of Pittsburgh School of Medicine, Pittsburgh PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ericka L. Fink
14Department of Critical Care Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erich Schmutzhard
15Department of Neurology, Medical University Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Kheradmand
16Departments of Neurology and Otolaryngology–Head & Neck Surgery, The Johns Hopkins Hospital, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fan Kee Hoo
17Department Of Neurology, Faculty of Medicine and Health Sciences, University Putra Malaysia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Kumar
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Animesh Das
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achal K Srivastava
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayush Agarwal
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarun Dua
2World Health Organization, Brain Health Unit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kameshwar Prasad
18Rajendra Institute of Medical Sciences, Ranchi-834009, Jharkhand, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drkameshwarprasad@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Objective To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.

Design Systematic review and meta-analysis

Eligibility criteria Studies enrolling consecutive COVID-19 patients (probable or confirmed) presenting with neurological manifestations.

Data sources PubMed, Medline, Cochrane library, clinicaltrials.gov and EMBASE from 31st December 2019 to 15th December 2020.

Data extraction and analysis Two authors independently screened titles and abstracts retrieved by literature search. Risk of bias was examined using Joanna Briggs Institute (JBI) scale. A random-effects meta-analysis was performed, and pooled prevalence and 95% Confidence Intervals (CI) were calculated for neurological manifestations. Odds ratio (OR) and 95%CI were calculated to determine the association of neurological manifestations with disease severity and mortality. Presence of heterogeneity was assessed using I-square, meta-regression, and subgroup analyses. Statistical analyses were conducted in R version 3.6.2.

Results Of 2,455 citations, 350 studies were included in this review, providing data on 145,634 COVID-19 patients, 89% of whom were hospitalized. Forty-one neurological manifestations (24 symptoms and 17 diagnoses) were identified. Pooled prevalence of the most common neurological symptoms included: fatigue (32%), myalgia (20%), taste impairment (21%), smell impairment (19%) and headache (13%). A low risk of bias was observed in 85% of studies; studies with higher risk of bias yielded higher prevalence estimates. Stroke was the most common neurological diagnosis (pooled prevalence-2%). In COVID-19 patients aged >60, the pooled prevalence of acute confusion/delirium was 34% and the presence of any neurological manifestations in this age group was associated with mortality (OR 1.80; 95%CI 1.11 to 2.91).

Conclusions Up to one-third of COVID-19 patients analysed in this review experienced at least one neurological manifestation. One in 50 patients experienced stroke. In those over 60, more than one-third had acute confusion/delirium; the presence of neurological manifestations in this group was associated with near doubling of mortality. Results must be interpreted keeping in view the limitations of observational studies and associated bias.

Systematic review registration PROSPERO CRD42020181867.

What is already known on this topic The frequency of neurological manifestations including fatigue, myalgia, taste and smell impairments, headache and dizziness in COVID-19 patients has been reported in a few systematic reviews and meta-analyses. However, considerable heterogeneity has been observed in terms of methodological quality of the studies, severity of the disease, mean age and hospitalization status of the patients. The evidence regarding the frequency of neurological diagnoses including stroke, encephalitis, Guillain Barré syndrome (GBS) is also limited to case reports and case series and no data exists thus far on the pooled prevalence estimates for neurological diagnoses in COVID-19 patients.

What this study adds To the best of the authors’ knowledge, this is the largest systematic review and meta-analysis to date (including 350 studies with data on 145,634 cases) summarizing the evidence on the frequency of the full spectrum of neurological manifestations in COVID-19 patients in the overall, young and elderly populations. For the first time, our review reports the pooled prevalence of stroke in COVID-19 patients. Risk of bias, old age and disease severity were potential determinants of the frequency and nature of neurological manifestations as well as its association with mortality. Our review also highlights the need to develop reporting standards for studies describing the frequency of clinical features. Moreover, we note that this will be the first systematic review and meta-analysis on this subject to include studies reported in all languages.

Competing Interest Statement

SHYC serves as a member of Board of Directors to the Neurocritical Care Society. KTT is being funded from Center for Disease Control and Prevention (CDC) on COVID-19 related research. TS was Chair/Co-Chair of the UKRI/NIHR COVID-19 Rapid Response and Rolling Funding Initiatives, is an Advisor to the UK COVID-19 Therapeutics Advisory Panel and a member of the MHRA COVID-19 Vaccines Benefit Risk Expert Working Group. EB reports grants from Italian Ministry of Health, grants from SOBI, personal fees from Arvelle Therapeutics, grants from American ALS Association, outside the submitted work. All other co-authors declare no competing interests.

Clinical Trial

Prospero Registration ID: CRD42020181867

Funding Statement

This review was supported in part by funding from the World Health Organization.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The full dataset and statistical codes will be available upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies
Shubham Misra, Kavitha Kolappa, Manya Prasad, Divya Radhakrishnan, Kiran T Thakur, Tom Solomon, Benedict Daniel Michael, Andrea Sylvia Winkler, Ettore Beghi, Alla Guekht, Carlos A. Pardo, Greta Karen Wood, Sherry Hsiang-Yi Chou, Ericka L. Fink, Erich Schmutzhard, Amir Kheradmand, Fan Kee Hoo, Amit Kumar, Animesh Das, Achal K Srivastava, Ayush Agarwal, Tarun Dua, Kameshwar Prasad
medRxiv 2021.04.20.21255780; doi: https://doi.org/10.1101/2021.04.20.21255780
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies
Shubham Misra, Kavitha Kolappa, Manya Prasad, Divya Radhakrishnan, Kiran T Thakur, Tom Solomon, Benedict Daniel Michael, Andrea Sylvia Winkler, Ettore Beghi, Alla Guekht, Carlos A. Pardo, Greta Karen Wood, Sherry Hsiang-Yi Chou, Ericka L. Fink, Erich Schmutzhard, Amir Kheradmand, Fan Kee Hoo, Amit Kumar, Animesh Das, Achal K Srivastava, Ayush Agarwal, Tarun Dua, Kameshwar Prasad
medRxiv 2021.04.20.21255780; doi: https://doi.org/10.1101/2021.04.20.21255780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8786)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10563)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1755)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1844)
  • Public and Global Health (3985)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)